Private Advisor Group, LLC Anavex Life Sciences Corp. Transaction History
Private Advisor Group, LLC
- $15.6 Billion
- Q3 2024
A detailed history of Private Advisor Group, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Private Advisor Group, LLC holds 47,413 shares of AVXL stock, worth $324,304. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,413
Previous 42,971
10.34%
Holding current value
$324,304
Previous $181,000
48.62%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AVXL
# of Institutions
157Shares Held
26.6MCall Options Held
673KPut Options Held
811K-
Black Rock Inc. New York, NY6.39MShares$43.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.55MShares$31.1 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$25.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.83MShares$12.5 Million0.0% of portfolio
-
Two Sigma Investments, LP New York, NY1.01MShares$6.93 Million0.01% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $533M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...